Novelix Pharmaceuticals Limited (BOM:536565)
India flag India · Delayed Price · Currency is INR
69.00
-1.05 (-1.50%)
At close: Nov 16, 2026

Novelix Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
46.5825.570.850.1-0.6-20.27
Depreciation & Amortization
2.710.980.380.380.560.8
Other Amortization
0.040.04---0.22
Loss (Gain) From Sale of Assets
-----4.57
Loss (Gain) From Sale of Investments
-----15
Other Operating Activities
10.868.150.23-2.97-5.144.6
Change in Accounts Receivable
-1,255-436.32-225.943.3-16.5222.79
Change in Inventory
-122.15-135.893.51-3.74-2.89-0.7
Change in Accounts Payable
1,008310.5384.12-0.520.53-11.15
Change in Other Net Operating Assets
5.683.07----
Operating Cash Flow
-303.3-223.89-136.85-3.43-24.0515.86
Operating Cash Flow Growth
------0.42%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-58.47-32.56-1.06--0.04-17.98
Sale of Property, Plant & Equipment
---0.18--
Investment in Securities
--30.21-1.3922.8415.08
Other Investing Activities
20.8915.330.163.07-22.04-4.69
Investing Cash Flow
-37.58-17.2329.31.860.75-7.6

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Debt Issued (Repaid)
7.73-----
Issuance of Common Stock
334.5263.9330.65---
Other Financing Activities
16.3-82.5---
Financing Cash Flow
358.53263.93113.15---

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
---0--0
Net Cash Flow
17.6522.85.61-1.57-23.38.26

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-361.77-256.45-137.91-3.43-24.1-2.12
Free Cash Flow Growth
------
Free Cash Flow Margin
-23.30%-19.38%-44.87%-7.58%-125.49%-2.38%
Free Cash Flow Per Share
-12.88-12.16-13.86-0.33-2.98-0.26
Levered Free Cash Flow
-401.5-244.56-159.54.4810.27-12.33
Unlevered Free Cash Flow
-399.82-244.42-159.54.4810.27-11.97

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Change in Working Capital
-363.49-258.62-138.3-0.96-18.8710.94